Switch theme
Sign up to access all valuation multiples
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
2002
n/a
LTM Revenue $301M
LTM EBITDA $40.7M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SonoScape has a last 12-month revenue (LTM) of $301M and a last 12-month EBITDA of $40.7M.
In the most recent fiscal year, SonoScape achieved revenue of $280M and an EBITDA of $29.5M.
SonoScape expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SonoScape valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $301M | XXX | $280M | XXX | XXX | XXX |
| Gross Profit | $193M | XXX | $178M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 64% | XXX | XXX | XXX |
| EBITDA | $40.7M | XXX | $29.5M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $30.7M | XXX | $27.5M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $32.7M | XXX | $19.8M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, SonoScape's stock price is CNY 33 (or $5).
SonoScape has current market cap of CNY 14.1B (or $2.0B), and EV of CNY 12.8B (or $1.8B).
See SonoScape trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.8B | $2.0B | XXX | XXX | XXX | XXX | $0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, SonoScape has market cap of $2.0B and EV of $1.8B.
SonoScape's trades at 6.4x EV/Revenue multiple, and 60.2x EV/EBITDA.
Equity research analysts estimate SonoScape's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SonoScape has a P/E ratio of 59.9x.
See valuation multiples for SonoScape and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV/Revenue | 5.9x | XXX | 6.4x | XXX | XXX | XXX |
| EV/EBITDA | 43.6x | XXX | 60.2x | XXX | XXX | XXX |
| EV/EBIT | 57.9x | XXX | 64.6x | XXX | XXX | XXX |
| EV/Gross Profit | 9.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 59.9x | XXX | 99.2x | XXX | XXX | XXX |
| EV/FCF | 44.6x | XXX | 128.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSonoScape's last 12 month revenue growth is 18%
SonoScape's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
SonoScape's rule of 40 is 44% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SonoScape's rule of X is 59% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for SonoScape and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 71% | XXX | -9% | XXX | XXX | XXX |
| Rule of 40 | 44% | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 59% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SonoScape acquired XXX companies to date.
Last acquisition by SonoScape was XXXXXXXX, XXXXX XXXXX XXXXXX . SonoScape acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was SonoScape founded? | SonoScape was founded in 2002. |
| Where is SonoScape headquartered? | SonoScape is headquartered in China. |
| Is SonoScape publicy listed? | Yes, SonoScape is a public company listed on SHE. |
| What is the stock symbol of SonoScape? | SonoScape trades under 300633 ticker. |
| When did SonoScape go public? | SonoScape went public in 2017. |
| Who are competitors of SonoScape? | Similar companies to SonoScape include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of SonoScape? | SonoScape's current market cap is $2.0B |
| What is the current revenue of SonoScape? | SonoScape's last 12 months revenue is $301M. |
| What is the current revenue growth of SonoScape? | SonoScape revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of SonoScape? | Current revenue multiple of SonoScape is 5.9x. |
| Is SonoScape profitable? | Yes, SonoScape is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SonoScape? | SonoScape's last 12 months EBITDA is $40.7M. |
| What is SonoScape's EBITDA margin? | SonoScape's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of SonoScape? | Current EBITDA multiple of SonoScape is 43.6x. |
| What is the current FCF of SonoScape? | SonoScape's last 12 months FCF is $39.9M. |
| What is SonoScape's FCF margin? | SonoScape's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of SonoScape? | Current FCF multiple of SonoScape is 44.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
